Pasithea Therapeutics Corp. · NASDAQ:KTTA
Coastlands Capital LP reported a 9.99% stake in Pasithea Therapeutics Corp. (Schedule 13G)
Event Feb 23, 2026 · Filed Feb 27, 2026
Coastlands Capital LP reported a 9.99% stake in Pasithea Therapeutics Corp., 2,394,765 shares, as a passive investor on Feb 23, 2026. Filed Feb 27, 2026 (Schedule 13G).
- Stake
- 9.99%
- Shares
- 2,394,765
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Coastlands Capital LP | 9.99% | 2,394,765 |
| Coastlands Capital Partners LP | 9.99% | 2,394,765 |
| Coastlands Capital GP LLC | 9.99% | 2,394,765 |
| Coastlands Capital LLC | 9.99% | 2,394,765 |
| Matthew D. Perry | 9.99% | 2,394,765 |
Source
Related
- Pasithea Therapeutics Corp.
- Coastlands Capital LP
- Pasithea Therapeutics Corp. shareholders
- Schedule 13G/A · Coastlands Capital LP · Jul 1, 2026
- Schedule 13G/A · Vivo Opportunity, LLC · Aug 14, 2026
- Schedule 13G/A · Opaleye Management Inc. · Jul 31, 2026
- Schedule 13G · Stonepine Capital Management, LLC · Jun 23, 2026
- Form 4 · Coastlands Capital LP · Jun 22, 2026
- Schedule 13G/A · Ameriprise Financial Inc · May 15, 2026